factor

(redirected from G-CSF)
Also found in: Dictionary, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • all
  • noun
  • verb

Synonyms for factor

Synonyms for factor

one of the individual entities contributing to a whole

one of the conditions or facts attending an event and having some bearing on it

Synonyms for factor

one of two or more integers that can be exactly divided into another integer

any of the numbers (or symbols) that form a product when multiplied together

an independent variable in statistics

be a contributing factor

consider as relevant when making a decision

References in periodicals archive ?
Glucocorticoids and granulocyte colony stimulating factor (G-CSF) are used to raise the granulocyte count and broad-spectrum antibiotics covering the most important bacterial or fungal agents to counter infection [4].
G-CSF requires five to seven days of injections in order to provide adequate numbers of stem cells for transplant.
The results of the coadministration group were significantly higher than those of the BMSC and G-CSF groups (P=0.016).
As shown in Figure 2, ALT and AST of liver cirrhosis rats in BMSCs group, BMSCs+ G-CSF group, BMSCs + JSSQ group, and JSSQ group showed different degrees of reduction after treatment (P < 0.01).
G-CSF (D0) concentrations were higher in patients with cardiovascular dysfunction (patients with cardiovascular dysfunction: median = 30.4pg/mL, IQR: 11.2-73.7; without dysfunction: median=11.0, IQR: 3.3-41.2; p = 0.03).
Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
Conclusions: The mean duration for recovery from leukopenia with G-CSF treatment in neonatal sepsis was less than 2 days and had no significant relationship with pre-GCSF absolute neutrophil count.
Univariable analysis for predictive factors identified three factors to be included in the multivariable model: the presence of visceral metastases (OR 4.85, 95% CI 0.85 to 27.7; p = 0.076), primary prophylaxis with G-CSF (OR 4.06, 95% CI 1.12 to 14.8; p=0.034), and development of any grade 3-4 toxicity (OR 6.13, 95% CI 1.98 to 34.35; p=0.039).
Seven days after treatment with G-CSF the difference between two groups in size of lumen (p =0.20) and plaque (p =0.12) was not significant.
Mann-Whitney U test was used to compare differences among groups, while Wilcoxon test was used to compare changes in course of G-CSF treatment.
To maintain the neutrophil count, granulocyte colony-stimulating factor (G-CSF) was administered from 5 to 10 [micro]g/kg/day and 15 [micro]g/kg/day, respectively (Figure 2).
Our previous results indicated that the LPS sensitivity could be induced by granulocyte colony-stimulating factor (G-CSF) pretreatment [9].
It is assumed that about 20% of cases are related to autoimmune disorders and about 40-50% of cases are unexplained RM G-CSF (Granulocyte Colony-stimulating Factor) is a glycoprotein that is secreted from endothelial cells, macrophages and some other immune system cells (6).